Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
BJU International|September 18, 2007
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomyShahrokh F Shariat, Robert S Svatek, Wareef Kabbani, et al.
World Journal of Urology|August 26, 2020
Essential elements of anaesthesia practice in ERAS programsGéraldine Pignot, Clément Brun, Maxime Tourret, et al.
European Urology|January 7, 2025
How To Write a Response to ReviewersAndrew J Vickers, Melissa Assel, Rodney L Dunn, et al.
BJU International|March 24, 2007
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancerFelix K-H Chun, Pierre I Karakiewicz, Alberto Briganti, et al.
World Journal of Urology|January 21, 2014
External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancerCédric Vallier, Pierre-Henri Savoie, Jean-Robert Delpero, et al.
Minerva Urology and Nephrology|December 18, 2025
SYNERGY in uro-oncology: navigating decisions in low-risk prostate cancerFabio Zattoni, Savio D Pandolfo, Gianluca Spena, et al.
Molecular and Clinical Oncology|January 26, 2016
Radiation therapy following targeted therapy in oligometastatic renal cell carcinomaGwenaelle Gravis, Marjorie Faure, Stanislas Rybikowski, et al.
BMC Urology|May 17, 2019
Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-upYoann Koskas, François Lannes, Nicolas Branger, et al.
Central European Journal of Urology|November 2, 2020
Uro-oncology in the era of social distancing: the principles of patient-centered online consultations during the COVID-19 pandemicRoman Sosnowski, Hubert Kamecki, Steven Joniau, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
BJU International|September 18, 2007
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomyShahrokh F Shariat, Robert S Svatek, Wareef Kabbani, et al.
World Journal of Urology|August 26, 2020
Essential elements of anaesthesia practice in ERAS programsGéraldine Pignot, Clément Brun, Maxime Tourret, et al.
European Urology|January 7, 2025
How To Write a Response to ReviewersAndrew J Vickers, Melissa Assel, Rodney L Dunn, et al.
BJU International|March 24, 2007
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancerFelix K-H Chun, Pierre I Karakiewicz, Alberto Briganti, et al.
World Journal of Urology|January 21, 2014
External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancerCédric Vallier, Pierre-Henri Savoie, Jean-Robert Delpero, et al.
Minerva Urology and Nephrology|December 18, 2025
SYNERGY in uro-oncology: navigating decisions in low-risk prostate cancerFabio Zattoni, Savio D Pandolfo, Gianluca Spena, et al.
Molecular and Clinical Oncology|January 26, 2016
Radiation therapy following targeted therapy in oligometastatic renal cell carcinomaGwenaelle Gravis, Marjorie Faure, Stanislas Rybikowski, et al.
BMC Urology|May 17, 2019
Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-upYoann Koskas, François Lannes, Nicolas Branger, et al.
Central European Journal of Urology|November 2, 2020
Uro-oncology in the era of social distancing: the principles of patient-centered online consultations during the COVID-19 pandemicRoman Sosnowski, Hubert Kamecki, Steven Joniau, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
Pageof 22